axcount Generika AG is the generics company of AxiCorp and its customers.

Lean structures and embedding in the AxiCorp Group give axcount optimum framework conditions.
For that reason axcount – with up to 20% more favourable prices – is always amongst the lowest priced generic medicines on the market and can even come out on top against dominant market players.
This foundation is further secured through the partnership with Biocon: because Biocon is one of the world's largest manufacturers of active pharmaceutical ingredients, axcount can extend its portfolio organically by adding interesting products.
Moreover, Biocon has a worldwide network of cooperation partners. For axcount this means more favourable purchasing prices for generic medicines. These benefits lead to a far more aggressive pricing strategy which makes axcount an even more attractive partner for sickness funds. In this way axcount will contribute to more competition on the German generics market in future, too.

Facts:

More than 40 million insured persons benefit from the rebate contract partnership of their sickness funds with axcount

High-demand RX and OTC portfolio which is permanently extended: the products are amongst the 100 ingredients for which demand is highest on the generic medicines market

The axcount portfolio includes the most important indications: allergy, antibiotics, antimycotics, flu, cardiovascular, gastrointestinal, neurology and psychiatry, pain, pain and fever, pain and rheumatism, metabolism, vitamins and minerals.